Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Macchi

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 5, 2025
Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE<sup>-/-</sup> miceChiara Macchi, Isabella Fichtner, Tasnim Mohamed, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Brain-Derived Neurotrophic Factor and Extracellular Vesicle-Derived miRNAs in an Italian Cohort of Individuals With Obesity: A Key to Explain the Link Between Depression and AtherothrombosisPatrizia Amadio, Chiara Macchi, Chiara Favero, et al.
European Heart Journal|July 9, 2018
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptorLorenzo Da Dalt, Massimiliano Ruscica, Fabrizia Bonacina, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 25, 2021
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro ModelsMiriam Longo, Marica Meroni, Erika Paolini, et al.
Cardiovascular Diabetology|November 27, 2025
Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunctionSerena Pelusi, Chiara Macchi, Francesco Malvestiti, et al.
International Journal of Molecular Sciences|November 11, 2022
PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle CellsMaria Francesca Greco, Alessandra Stefania Rizzuto, Marta Zarà, et al.
Atherosclerosis|August 31, 2020
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE studyNicola Ferri, Massimiliano Ruscica, Daniela Coggi, et al.
Open Heart|October 10, 2025
<i><b>PCSK9</b></i> <b>genetic variants, carotid atherosclerosis and vascular remodelling</b>Daniela Coggi, Joey Ward, Chiara Macchi, et al.
Biomedicines|August 6, 2021
Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE StudyDaniela Coggi, Beatrice Frigerio, Alice Bonomi, et al.
Atherosclerosis|June 2, 2024
Advancements in risk stratification and management strategies in primary cardiovascular preventionFotios Barkas, Yusuf Ziya Sener, Pelin Arabacilar Golforoush, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 5, 2025
Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE<sup>-/-</sup> miceChiara Macchi, Isabella Fichtner, Tasnim Mohamed, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Brain-Derived Neurotrophic Factor and Extracellular Vesicle-Derived miRNAs in an Italian Cohort of Individuals With Obesity: A Key to Explain the Link Between Depression and AtherothrombosisPatrizia Amadio, Chiara Macchi, Chiara Favero, et al.
European Heart Journal|July 9, 2018
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptorLorenzo Da Dalt, Massimiliano Ruscica, Fabrizia Bonacina, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 25, 2021
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro ModelsMiriam Longo, Marica Meroni, Erika Paolini, et al.
Cardiovascular Diabetology|November 27, 2025
Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunctionSerena Pelusi, Chiara Macchi, Francesco Malvestiti, et al.
International Journal of Molecular Sciences|November 11, 2022
PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle CellsMaria Francesca Greco, Alessandra Stefania Rizzuto, Marta Zarà, et al.
Atherosclerosis|August 31, 2020
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE studyNicola Ferri, Massimiliano Ruscica, Daniela Coggi, et al.
Open Heart|October 10, 2025
<i><b>PCSK9</b></i> <b>genetic variants, carotid atherosclerosis and vascular remodelling</b>Daniela Coggi, Joey Ward, Chiara Macchi, et al.
Biomedicines|August 6, 2021
Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis-The IMPROVE StudyDaniela Coggi, Beatrice Frigerio, Alice Bonomi, et al.
Atherosclerosis|June 2, 2024
Advancements in risk stratification and management strategies in primary cardiovascular preventionFotios Barkas, Yusuf Ziya Sener, Pelin Arabacilar Golforoush, et al.
Pageof 8